Skip to main content
Tech.euFundingExplorerBeta

UTokyo Innovation Platform

Investor profile

Venture capital

UTokyo Innovation Platform has backed 1 European tech company across 2 funding rounds between 2022 and 2026, joining rounds totalling €76M. Most active in Healthtech. Data as of 4 Nov 2026.

Also recorded as: UTokyo Innovation Platform Co.

Deals
2
distinct rounds
Companies
1
backed
Active span
2022–2026
5 yrs
Total round €
€76M
sum of rounds joined

Deals by year

distinct rounds / year
UTokyo Innovation Platform — deals by year — interactive chart.
Data table
UTokyo Innovation Platform — deals by year
20221
20261

Top sectors

by deals
UTokyo Innovation Platform — top sectors — interactive chart.
Data table
UTokyo Innovation Platform — top sectors
Healthtech2

Stages

by deals
UTokyo Innovation Platform — stages — interactive chart.
Data table
UTokyo Innovation Platform — stages
Series B1
Series C1

Countries

by deals
UTokyo Innovation Platform — countries — interactive chart.
Data table
UTokyo Innovation Platform — countries
UK2

Co-investment network

shared rounds
Co-investment network — interactive chart.
UTokyo Innovation Platform — 2 dealsUTokyo Innovation PlatformIP Group PLC — 2 shared deals · click to openIP Group PLCM Ventures — 2 shared deals · click to openM VenturesPfizer Ventures — 2 shared deals · click to openPfizer VenturesTaiho Ventures — 2 shared deals · click to openTaiho VenturesCambridge Innovation Capital — 1 shared deals · click to openCambridge Innovation CapitalFast Track Initiative — 1 shared deals · click to openFast Track InitiativeFast Track Initiative (FTI) — 1 shared deals · click to openFast Track Initiative (FTI)Seroba Life Sciences — 1 shared deals · click to openSeroba Life Sciences

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Storm TherapeuticsUK2€76M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Storm TherapeuticsSeries C€48M2026-04
Storm TherapeuticsSeries B€28M2022-12
← Back to investors